Altre lingue Kukje Pharma Co., Ltd.

Azioni

A002720

KR7002720001

Prezzo di chiusura Korea S.E. Altri mercati azionari 00:00:00 03/07/2024			Variaz. 5gg	Var. 1 gen.
5.850 ^KRW	+4,84%		-5,65%	-1,18%

16/05	Kukje Pharma Co., Ltd. riporta i risultati degli utili per il primo trimestre conclusosi il 31 marzo 2024	CI
18/03	Kukje Pharma Co., Ltd. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Kukje Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	16/05
Kukje Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	18/03
Kukje Pharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Kukje Pharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Kukje Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23
Kukje Pharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/11/22
Kukje Pharma Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16/08/22
Kukje Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16/05/22
Kukje Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	10/03/22
OncoPep, Inc. announced that it has received $11 million in funding from TERA SCIENCE Co.,LTD, Crystal Bioscience Inc., Kukje Pharma Co., Ltd.	09/12/21
Kukje Pharma Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/11/21
Coronavirus infects Asia stocks with exposure to China	28/01/20
ASX 200 : Coronavirus infects Asia stocks with exposure to China	28/01/20
Tranche Update on Kukje Pharmaceutical Industrial Co. Ltd.'s Equity Buyback Plan announced on November 2, 2016.	12/01/17
Kukje Pharmaceutical Industrial Co. Ltd.'s Equity Buyback announced on November 2, 2016, has closed with 300,000 shares, representing 1.81% for KRW 1,371.73 million.	10/01/17
Kukje Pharmaceutical Industrial Co. Ltd. authorizes a Buyback Plan.	02/11/16
Kukje Pharmaceutical Industrial Co. Ltd. announces an Equity Buyback for 300,000 shares.	02/11/16
Kukje Pharmaceutical Industrial Co. Ltd. and other buyers cancelled the acquisition of partial stake in cosmetics business from Kukje Pharmaceutical Industrial Co. Ltd.	11/06/16
Kukje Pharmaceutical Industrial Co. Ltd. and other buyers agreed to acquire partial stake in cosmetics business from Kukje Pharmaceutical Industrial Co. Ltd. for KRW 2 billion.	11/06/15
Kukje Pharmaceutical Industrial Co. Ltd.’s Equity Buyback announced on August 9, 1994 has expired.	02/04/15

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Kukje Pharma Co., Ltd.

Azioni

A002720

KR7002720001

Altre lingue

Filtri